Trials / Unknown
UnknownNCT00519259
Tolerability and Safety of 30, 45, and 60 mg of Sublingual Lobeline. - 1
Tolerability, Safety, and Pharmacokinetics of Repeated Sublingual Doses of Lobeline
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (planned)
- Sponsor
- National Institute on Drug Abuse (NIDA) · NIH
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess safety and pharmacokinetics of sublingual lobeline in healthy normal volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lobeline |
Timeline
- Start date
- 2006-02-01
- First posted
- 2007-08-22
- Last updated
- 2017-01-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00519259. Inclusion in this directory is not an endorsement.